![](/img/cover-not-exists.png)
High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma.
Gianni, A M, Tarella, C, Bregni, M, Siena, S, Lombardi, F, Gandola, L, Caracciolo, D, Stern, A, Bonadonna, G, Boccadoro, MVolume:
12
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.1994.12.3.503
Date:
March, 1994
File:
PDF, 662 KB
english, 1994